Capital Impact Advisors’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-20,380
| Closed | -$1M | – | 45 |
|
|
2024
Q2 | $1M | Buy |
20,380
+2,821
| +16% | +$139K | 2.83% | 5 |
|
|
2024
Q1 | $602K | Sell |
17,559
-29,088
| -62% | -$998K | 0.78% | 56 |
|
|
2023
Q4 | $1.72M | Buy |
46,647
+550
| +1% | +$20.3K | 2.26% | 5 |
|
|
2023
Q3 | $934K | Buy |
46,097
+3,786
| +9% | +$76.7K | 1.56% | 14 |
|
|
2023
Q2 | $866K | Buy |
42,311
+16,834
| +66% | +$344K | 0.95% | 21 |
|
|
2023
Q1 | $384K | Buy |
25,477
+1,699
| +7% | +$25.6K | 0.47% | 99 |
|
|
2022
Q4 | $566K | Buy |
23,778
+4,601
| +24% | +$110K | 0.55% | 67 |
|
|
2022
Q3 | $487K | Buy |
19,177
+1,132
| +6% | +$28.7K | 0.49% | 79 |
|
|
2022
Q2 | $631K | Buy |
18,045
+2,705
| +18% | +$94.6K | 0.58% | 59 |
|
|
2022
Q1 | $757K | Buy |
+15,340
| New | +$757K | 0.55% | 76 |
|
|
2021
Q4 | – | Sell |
-15,052
| Closed | -$1.61M | – | 148 |
|
|
2021
Q3 | $1.61M | Sell |
15,052
-30,102
| -67% | -$3.22M | 0.64% | 69 |
|
|
2021
Q2 | $6.02M | Buy |
45,154
+18,262
| +68% | +$2.43M | 1.94% | 4 |
|
|
2021
Q1 | $3.33M | Sell |
26,892
-70,108
| -72% | -$8.68M | 1.17% | 34 |
|
|
2020
Q4 | $13.7M | Buy |
97,000
+57,000
| +143% | +$8.05M | 3.37% | 1 |
|
|
2020
Q3 | $3.04M | Buy |
+40,000
| New | +$3.04M | 0.9% | 41 |
|